Med-Tech Innovation July 30, 2024
Arjun Luthra

On the cover of Med-Tech Innovation Magazine, Arjun Luthra, BioInteractions’ Commercial Director, discusses how the company’s surface active therapeutics are being used for the prevention and protection of medical devices against infections.

Using Surface Active Therapeutics for the prevention and protection of medical devices against infections is becoming more and more important, as the number of healthcare associated infections (HCAIs) rises. While researchers have been able to pinpoint some causes of HCAIs, there is still a need to protect complex surfaces, like implants, from device-related infections, and surgical equipment to be protected from germs and microbes. Safeguarding all surfaces in healthcare is critical to evolving the infection prevention infrastructure for patients, professionals, providers and visitors. The demand for implantable devices...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Provider
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article